Ira L Goldknopf

Summary

Publications

  1. ncbi request reprint Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease
    Ira L Goldknopf
    Power3 Medical Products, Inc, The Woodlands, TX, USA
    Biochem Biophys Res Commun 342:1034-9. 2006
  2. doi request reprint Abnormal serum concentrations of proteins in Parkinson's disease
    Ira L Goldknopf
    Power3 Medical Products, Inc, The Woodlands, TX 77381, USA
    Biochem Biophys Res Commun 389:321-7. 2009
  3. ncbi request reprint Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls
    Ira L Goldknopf
    Power3 Medical Products, Inc, The Woodlands, TX, USA
    Curr Alzheimer Res 9:1149-67. 2012
  4. ncbi request reprint 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases
    Essam A Sheta
    Power3 Medical Products, Inc, The Woodlands, TX 77381, USA
    Expert Rev Proteomics 3:45-62. 2006
  5. ncbi request reprint Molecular diagnostics and proteomics on the outskirts of personalized medicine
    Ira L Goldknopf
    Power3 Medical Products, Inc, The Woodlands, TX 77381, USA
    Expert Rev Mol Diagn 7:339-43. 2007
  6. doi request reprint Blood-based proteomics for personalized medicine: examples from neurodegenerative disease
    Ira L Goldknopf
    Expert Rev Proteomics 5:1-8. 2008

Detail Information

Publications6

  1. ncbi request reprint Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease
    Ira L Goldknopf
    Power3 Medical Products, Inc, The Woodlands, TX, USA
    Biochem Biophys Res Commun 342:1034-9. 2006
    ..The differential expression of the complement proteins provides potentially useful biomarkers as well as evidence for the involvement of inflammatory processes in the pathogenesis of ALS and PD...
  2. doi request reprint Abnormal serum concentrations of proteins in Parkinson's disease
    Ira L Goldknopf
    Power3 Medical Products, Inc, The Woodlands, TX 77381, USA
    Biochem Biophys Res Commun 389:321-7. 2009
    ....
  3. ncbi request reprint Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls
    Ira L Goldknopf
    Power3 Medical Products, Inc, The Woodlands, TX, USA
    Curr Alzheimer Res 9:1149-67. 2012
    ..Optimization is addressed by taking into account whether the patients and controls have or do not have increased risk of AD die to the presence or absence of Apolipoprotein E4...
  4. ncbi request reprint 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases
    Essam A Sheta
    Power3 Medical Products, Inc, The Woodlands, TX 77381, USA
    Expert Rev Proteomics 3:45-62. 2006
    ..The potential for pathway measurement in blood tests for differential diagnosis, disease burden and therapeutic monitoring is also outlined...
  5. ncbi request reprint Molecular diagnostics and proteomics on the outskirts of personalized medicine
    Ira L Goldknopf
    Power3 Medical Products, Inc, The Woodlands, TX 77381, USA
    Expert Rev Mol Diagn 7:339-43. 2007
  6. doi request reprint Blood-based proteomics for personalized medicine: examples from neurodegenerative disease
    Ira L Goldknopf
    Expert Rev Proteomics 5:1-8. 2008